Published in Appl Microbiol on September 01, 1965
Phosphohydrolases of a Bacillus subtilis mutant accumulating inosine and hypoxanthine. J Bacteriol (1967) 0.91
Production of nucleic acid-related substances by fermentation processes. 33. Accumulation of inosine by a mutant of Brevibacterium ammoniagenes. Appl Microbiol (1970) 0.90
Production of guanosine-5'-monophosphate and inosine-5'-monophosphate by fermentation. Appl Microbiol (1966) 0.85
The accumulation of xanthosine by a guanine-less mutant of Aerobacter aerogenes. J Biol Chem (1954) 3.09
Guanosine 5'-phosphate reductase and its role in the interconversion of purine nucleotides. J Biol Chem (1960) 2.74
The production of amino acids by fermentation processes. Adv Appl Microbiol (1959) 1.41
ANTAGONISM BY PURINES AND DERIVATIVES IN THE NUTRITION OF A BACILLUS SUBTILIS MUTANT. Arch Biochem Biophys (1964) 1.24
Antagonisms between purines and purine analogues in auxotrophs of Salmonella typhimurium. J Bacteriol (1961) 1.09
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother (1974) 8.84
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. Antimicrob Agents Chemother (1974) 6.72
Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother (1972) 5.23
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 4.93
Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J Antibiot (Tokyo) (1979) 4.82
Mutants of yeast defective in iso-1-cytochrome c. Genetics (1974) 4.73
Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell (1989) 4.47
Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to beta-lactamase degradation. Antimicrob Agents Chemother (1973) 4.45
Saccharification of Complex Cellulosic Substrates by the Cellulase System from Clostridium thermocellum. Appl Environ Microbiol (1982) 4.20
Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science (1969) 3.89
A deletion map of cyc1 mutants and its correspondence to mutationally altered iso-1-cytochromes c of yeast. Genetics (1975) 3.48
Control of antibiotic biosynthesis. Microbiol Rev (1980) 3.44
Sequencing of a Clostridium thermocellum gene (cipA) encoding the cellulosomal SL-protein reveals an unusual degree of internal homology. Mol Microbiol (1993) 3.28
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation. Antimicrob Agents Chemother (1974) 3.22
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95
The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriol Rev (1977) 2.89
Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studies. Antimicrob Agents Chemother (1972) 2.88
Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. J Antimicrob Chemother (1978) 2.75
Mapping and gene conversion studies with the structural gene for iso-1-cytochrome C in yeast. Genetics (1975) 2.65
Identification and mutational relocation of the AUG codon initiating translation of iso-1-cytochrome c in yeast. J Biol Chem (1971) 2.57
Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39
Chemically Defined Minimal Medium for Growth of the Anaerobic Cellulolytic Thermophile Clostridium thermocellum. Appl Environ Microbiol (1981) 2.31
Ivermectin: a potent new antiparasitic agent. Science (1983) 2.31
Nutritional Studies on Xanthan Production by Xanthomonas campestris NRRL B1459. Appl Environ Microbiol (1979) 2.27
Conversion of penicillin N to cephalosporin(s) by cell-free extracts of Cephalosporium acremonium. Biochem Biophys Res Commun (1976) 2.27
Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies. Antimicrob Agents Chemother (1972) 2.25
Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10
High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A (1994) 2.09
Effect of primary metabolites on secondary metabolism. Annu Rev Microbiol (1977) 2.08
Cell-free conversion of delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic with the properties of isopenicillin N in Cephalosporium acremonium. Biochem J (1979) 2.08
Cardiac arrest during intramedullary nailing for femoral metastases. J Bone Joint Surg Br (1993) 2.07
Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain (1996) 2.05
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Neuroaxial blockade and psoriasis. Int J Obstet Anesth (2007) 2.03
Organization and expression of non-Alu family interspersed repetitive DNA sequences in the mouse genome. J Mol Biol (1984) 1.96
Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J Bacteriol (2001) 1.90
Cellular response to modulated radiation fields. Phys Med Biol (2007) 1.88
Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity. J Antibiot (Tokyo) (1987) 1.87
Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother (1995) 1.86
A redrawn Vandenberg and Kuse mental rotations test: different versions and factors that affect performance. Brain Cogn (1995) 1.71
Demonstration of the UAA ochre codon in bakers yeast by amino-acid replacements in iso-1-cytochrome c. J Mol Biol (1972) 1.66
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
Determinants of chemotactic signal amplification in Escherichia coli. J Mol Biol (2001) 1.64
Arithmetic skills in patients with unilateral cerebral lesions. Cortex (1986) 1.63
Age is not an impediment to effective use of patient-controlled analgesia by surgical patients. Anesthesiology (2000) 1.62
How do antibiotic-producing microorganisms avoid suicide? Ann N Y Acad Sci (1974) 1.60
Biochemistry and regulation of streptomycin and mannosidostreptomycinase (alpha-D-mannosidase) formation. Bacteriol Rev (1970) 1.60
Tyrosine substitutions resulting from suppression of amber mutants of iso-1-cytochrome c in yeast. J Mol Biol (1973) 1.59
Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol (1995) 1.59
Congenital testicular maldescent: significance of the complete hernial sac. Br J Urol (1995) 1.56
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proc Natl Acad Sci U S A (1998) 1.50
The anchorage function of CipA (CelL), a scaffolding protein of the Clostridium thermocellum cellulosome. Proc Natl Acad Sci U S A (1995) 1.49
Reducing the risk of retained throat packs after surgery. Br J Oral Maxillofac Surg (2012) 1.48
Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.48
Lysine control of penicillin biosynthesis. Can J Microbiol (1972) 1.48
Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis (1989) 1.43
Improved procedure for production of cytochalasin E and tremorgenic mycotoxins by Aspergillus clavatus. Appl Environ Microbiol (1976) 1.42
Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives. J Bacteriol (1997) 1.42
Reduced free radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients. Diabet Med (1988) 1.40
The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey. Int J Clin Pract (2003) 1.40
Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia. Australas Radiol (2002) 1.40
Cerebral arterial narrowing with nicotine patch. Lancet (1993) 1.40
Current imaging of childhood urinary infections: prospective survey. BMJ (1992) 1.39
T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae. Infect Immun (1989) 1.39
Phosphonomycin. V. Evaluation in mice. Antimicrob Agents Chemother (Bethesda) (1969) 1.38
Cell-free ring expansion of penicillin N to deacetoxycephalosporin C by Cephalosporium acremonium CW-19 and its mutants. Proc Natl Acad Sci U S A (1978) 1.37
L-lysine epsilon-aminotransferase involved in cephamycin C synthesis in Streptomyces lactamdurans. Antimicrob Agents Chemother (1980) 1.36
An erythromycin analog produced by reprogramming of polyketide synthesis. Proc Natl Acad Sci U S A (1993) 1.35
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
Nitrogen nutrition and regulation of cephalosporin production in Streptomyces clavuligerus. Can J Microbiol (1979) 1.33
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Carbon catabolite regulation of cephalosporin production in Streptomyces clavuligerus. Antimicrob Agents Chemother (1978) 1.29
Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature (2001) 1.29
Biochemistry of penicillin and cephalosporin fermentations. Lloydia (1974) 1.28
Acoustic modeling of American English /r/. J Acoust Soc Am (2000) 1.28
Curvature and tortuosity of the superficial femoral artery: a possible risk factor for peripheral arterial disease. J Appl Physiol (1985) (2006) 1.26
Riboflavin oversynthesis. Annu Rev Microbiol (1972) 1.26
In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys J (1996) 1.25
Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ (2000) 1.22
Alteration of permeability for the release of metabolites from the microbial cell. Curr Top Microbiol Immunol (1968) 1.22
Industrial microbiology. Science (1981) 1.22
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry (2006) 1.22
Anatomy of pilon fractures of the distal tibia. J Bone Joint Surg Br (2005) 1.19
Studies on the ring-cyclization and ring-expansion enzymes of beta-lactam biosynthesis in Cephalosporium acremonium. Can J Microbiol (1983) 1.19
Regulation of extracellular protease production in Candida lipolytica. Biochim Biophys Acta (1977) 1.19
Lysine inhibition of in vivo homocitrate synthesis in Penicillium chrysogenum. J Gen Microbiol (1974) 1.18
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry (1997) 1.17
Studies on the total synthesis of an enzyme. V. The preparation of enzymatically active material. J Am Chem Soc (1969) 1.17
Fosfomycin: Laboratory studies. Chemotherapy (1977) 1.17
Catabolism of betaine and its relationship to cobalamin overproduction. Biochim Biophys Acta (1971) 1.17
A pure enzyme catalyzing penicillin biosynthesis. Science (1984) 1.16
Incorporation of 3H and 14C from (6 alpha-3H)penicillin N and (10-14C,6 alpha-3H) penicillin N into deacetoxycephalosporin C. Biochem J (1980) 1.15
Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. Biochem Biophys Res Commun (1964) 1.15
Development of human liver UDP-glucuronosyltransferases. Dev Pharmacol Ther (1989) 1.13